Our data, combined with the finding that CTRP3 prevents alcohol-induced fatty liver disease [55], identifies CTRP3 as an ideal candidate to develop novel treatments for alcoholic fatty liver disease. This evidence concerns the gene C1QTNF3 and alcoholic fatty liver disease.